Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.4 (
adenosine deaminase
)
5,136
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Models of rats with
iron deficiency anemia
(
IDA
) were established, and changes in development of the thymus and spleen and
adenosine deaminase
(
ADA
) activity in them studied. The size and weight of the thymus in
IDA
rats were decreased, which suggested that the development of the thymus was lowered; but the size and weight of the spleen in
IDA
group were increased.
ADA
activities of the thymus and the spleen in
IDA
rats were significantly decreased by 32.98% and 25.89%, respectively. One week after iron supplement, the weight of the thymus and spleen in IDS group returned to normal level (P greater than 0.05), and their
ADA
activity also significantly increased, but
ADA
activity of the thymus tissue did not return to the normal. The results suggested that the changes in
ADA
activity of the thymus and spleen tissues were related to iron deficiency. Stepwise regression analysis suggested that there was a negative correlation between
ADA
activity of the thymus tissue and FEP/Hb ratio.
...
PMID:[Influence of iron deficiency anemia on development of thymus and spleen and adenosine deaminase activity in rats]. 236 44